Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Bowlus

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Hepatology (Baltimore, Md.)|November 28, 2012
Antimitochondrial antibody heterogeneity and the xenobiotic etiology of primary biliary cirrhosisRichy C Y Chen, Phornnop Naiyanetr, Shang-An Shu, et al.
Journal of Hepatology|May 1, 2018
Lysyl oxidase-like protein 2 (LOXL2) modulates barrier function in cholangiocytes in cholestasisMarion J Pollheimer, Silvia Racedo, Amanda Mikels-Vigdal, et al.
The New England Journal of Medicine|August 18, 2016
A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary CholangitisFrederik Nevens, Pietro Andreone, Giuseppe Mazzella, et al.
Journal of Autoimmunity|September 25, 2019
The challenges of primary biliary cholangitis: What is new and what needs to be doneBenedetta Terziroli Beretta-Piccoli, Giorgina Mieli-Vergani, Diego Vergani, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 11, 2023
NCCN Guidelines® Insights: Biliary Tract Cancers, Version 2.2023Al B Benson, Michael I D'Angelica, Thomas Abrams, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Hepatology (Baltimore, Md.)|November 28, 2012
Antimitochondrial antibody heterogeneity and the xenobiotic etiology of primary biliary cirrhosisRichy C Y Chen, Phornnop Naiyanetr, Shang-An Shu, et al.
Journal of Hepatology|May 1, 2018
Lysyl oxidase-like protein 2 (LOXL2) modulates barrier function in cholangiocytes in cholestasisMarion J Pollheimer, Silvia Racedo, Amanda Mikels-Vigdal, et al.
The New England Journal of Medicine|August 18, 2016
A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary CholangitisFrederik Nevens, Pietro Andreone, Giuseppe Mazzella, et al.
Journal of Autoimmunity|September 25, 2019
The challenges of primary biliary cholangitis: What is new and what needs to be doneBenedetta Terziroli Beretta-Piccoli, Giorgina Mieli-Vergani, Diego Vergani, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 11, 2023
NCCN Guidelines® Insights: Biliary Tract Cancers, Version 2.2023Al B Benson, Michael I D'Angelica, Thomas Abrams, et al.
Pageof 3